Mary Lucas

Systemic sclerosis sine scleroderma: Demographic, clinical, and serologic features and survival in forty-eight patients

Hadi Poormoghim, Mary Lucas, Noreen Fertig et al. · Arthritis & Rheumatism · 2000 · 308 citations · Full text

Medicine, Clinical Sciences, Internal Medicine +13

Patients with non-Jo-1 anti-tRNA-synthetase autoantibodies have worse survival than Jo-1 positive patients

Rohit Aggarwal, Elaine Cassidy, Noreen Fertig et al. · Annals of the Rheumatic Diseases · 2013 · 306 citations · Full text

Life Sciences, Immunology, Internal Medicine +17

Anti–signal recognition particle autoantibody in patients with and patients without idiopathic inflammatory myopathy

Amy Kao, David Lacomis, Mary Lucas et al. · Arthritis & Rheumatism · 2004 · 286 citations

Life Sciences, Immunology, Pathology +17

Skin thickness progression rate: a predictor of mortality and early internal organ involvement in diffuse scleroderma

Tatiana Sofia Rodrı́guez-Reyna, Mary Lucas, Noreen Fertig et al. · Annals of the Rheumatic Diseases · 2010 · 253 citations

Medicine, Dermatology, Internal Medicine +13

Treatment of antisynthetase‐associated interstitial lung disease with tacrolimus

Margaret R. Wilkes, Susan M. Sereika, Noreen Fertig et al. · Arthritis & Rheumatism · 2005 · 239 citations

Medicine, Immunology, Internal Medicine +16